PathCare has introduced an antibody test that is capable of detecting antibodies directed against the SARS-CoV-2 spike (“S”) protein, induced by SARS-CoV-2 vaccines or by natural infection. Diagnostic assays previously introduced only target the nucleocapsid (“N”) protein and will therefore not be able to detect an antibody response from vaccines

Serological assays for SARS-COV-2 vaccine responses